By
Reuters
Published
June 26, 2026
Unilever is exploring a bid for Thorne, a US supplements maker valued at up to $4 billion, the Financial Times reported on Friday, as the consumer goods group accelerates its pivot towards beauty and wellbeing brands.
Thorne was acquired by LVMH-backed private equity firm L Catterton for $680 million in 2023. Thorne has attracted strategic interests, including a bid from consumer healthcare group Haleon, two sources familiar with the matter had told Reuters.
Unilever is among several bidders for the South Carolina-based company, which sells dietary supplements including magnesium and omega-3 primarily in the US, according to FT. Unilever and L Catterton declined to comment. Thorne and Haleon could not be immediately reached for comment.
Thorne announced that it had crossed $500 million in annual revenue in 2025, CNBC reported. The business has maintained a 30% compound annual growth rate since its acquisition by L Catterton in 2023 and expects to reach a sales total of $650 million this year.
FashionNetwork.com with Reuters
© Thomson Reuters 2026 All rights reserved.
